Free equity investment tool of Japanese companies

Financial Statement Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Fuso Pharmaceutical Industries

Kuraray

Kao

大正製薬ホールディングス

TSUMURA & CO.

ダイセル

塩野義製薬

Nihon Parkrizing

ADEKA

持田製薬

エスケー化研

ROHTO PHARMACEUTICAL

The Nippon Synthetic Chemical Industry

HISAMITSU PHARMACEUTICAL

JSR

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nittetsu Mining

クラリオン

クラリオン

クラリオン

クラリオン

Financial Statement Details: Okura Industrial+HISAMITSU PHARMACEUTICAL (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Statement data

F/S Outline: Okura Industrial+HISAMITSU PHARMACEUTICAL (Annual )

Switch ViewU-ChartU-Chart and F/SF/S

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2012-12-31  *  Total: ¥ 85 B  *  Net: ¥ 34 B  (Ratio: 39.95%)	[BS] 2013-02-28  *  Total: ¥ 214 B  *  Net: ¥ 167 B  (Ratio: 78.42%)
Financial Statement Details	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Cash etc.	¥ 7 B	¥ 41 B
Other Current Assets	¥ 34 B	¥ 66 B
Tangible Assets	¥ 35 B	¥ 43 B
Intangible Assets	¥ 185 M	¥ 17 B
Investment etc.	¥ 7 B	¥ 46 B
Total Assets	¥ 85 B	¥ 214 B
Current Liabilities	¥ 36 B	¥ 34 B
Fixed Liabilities	¥ 14 B	¥ 11 B
Capital stock	¥ 8 B	¥ 8 B
Capital surplus etc.	¥ 25 B	¥ 159 B
Liabilities and net assets	¥ 85 B	¥ 214 B
Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2012-12-31  *  Sales: ¥ 85 B  *  Income: ¥ 1 B  (Ratio: 1.84%)	[PL] 2013-02-28  *  Sales: ¥ 142 B  *  Income: ¥ 18 B  (Ratio: 13.17%)
Financial Statement Details	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Sales	¥ 85 B	¥ 142 B
Cost of Sales	¥ 74 B	¥ 51 B
Gross profit	¥ 11 B	¥ 91 B
Other income	¥ 426 M	¥ 8 B
SG&A	¥ 9 B	¥ 65 B
Other expenses	¥ 1 B	¥ 15 B
Net income	¥ 1 B	¥ 18 B
Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large
U-Chart	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
	[CF] 2012-12-31  *  OCF: ¥ 8 B  *  Cash: ¥ -343 M	[CF] 2013-02-28  *  OCF: ¥ 32 B  *  Cash: ¥ +16 B
Financial Statement Details	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Operating CF	¥ 8 B	¥ 32 B
Investment CF	¥ -3 B	¥ -7 B
Financial CF	¥ -5 B	¥ -9 B
Foreign Exchange Effects	¥ 61 M	¥ 1 B
Net Change in Cash	¥ -343 M	¥ 16 B
Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2012-12-31  *  Income: ¥ 1 B  *  Net: ¥ +1 B	[SS] 2013-02-28  *  Income: ¥ 18 B  *  Net: ¥ +18 B
Financial Statement Details	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Issuance of new shares	-	-
Dividends from surplus	¥ -306 M	¥ -5 B
Net income	¥ 1 B	¥ 18 B
Purchase of treasury stock	¥ -216 M	¥ -1 M
Other Change in Stockholders Equity	-	¥ -1 M
Other Change in Net Assets	¥ 420 M	¥ 5 B
Net Change in Net Assets	¥ 1 B	¥ 18 B

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2012-12-31  *  Total: ¥ 85 B  *  Net: ¥ 30 B  (Ratio: 35.54%)	[BS] 2013-02-28  *  Total: ¥ 200 B  *  Net: ¥ 168 B  (Ratio: 83.96%)
Financial Statement Details	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Cash etc.	¥ 4 B	¥ 34 B
Other Current Assets	¥ 33 B	¥ 47 B
Tangible Assets	¥ 28 B	¥ 30 B
Intangible Assets	¥ 65 M	¥ 6 B
Investment etc.	¥ 18 B	¥ 81 B
Total Assets	¥ 85 B	¥ 200 B
Current Liabilities	¥ 41 B	¥ 24 B
Fixed Liabilities	¥ 13 B	¥ 8 B
Capital stock	¥ 8 B	¥ 8 B
Capital surplus etc.	¥ 21 B	¥ 159 B
Liabilities and net assets	¥ 85 B	¥ 200 B
Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2012-12-31  *  Sales: ¥ 65 B  *  Income: ¥ 976 M  (Ratio: 1.50%)	[PL] 2013-02-28  *  Sales: ¥ 122 B  *  Income: ¥ 18 B  (Ratio: 15.08%)
Financial Statement Details	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Sales	¥ 65 B	¥ 122 B
Cost of Sales	¥ 59 B	¥ 40 B
Gross profit	¥ 6 B	¥ 81 B
Other income	¥ 1 B	¥ 1 B
SG&A	¥ 5 B	¥ 51 B
Other expenses	¥ 1 B	¥ 13 B
Net income	¥ 976 M	¥ 18 B
Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2012-12-31  *  Income: ¥ 976 M  *  Net: ¥ +870 M	[SS] 2013-02-28  *  Income: ¥ 18 B  *  Net: ¥ +14 B
Financial Statement Details	Okura Industrial (2012-12-31)	HISAMITSU PHARMACEUTICAL (2013-02-28)
Issuance of new shares	-	-
Dividends from surplus	¥ -306 M	¥ -5 B
Net income	¥ 976 M	¥ 18 B
Purchase of treasury stock	¥ -216 M	-
Other Change in Stockholders Equity	-	¥ -1 M
Other Change in Net Assets	¥ 416 M	¥ 2 B
Net Change in Net Assets	¥ 870 M	¥ 14 B

Related Information: Okura Industrial  HISAMITSU PHARMACEUTICAL 

Statement Type

Annual : Okura Industrial+HISAMITSU PHARMACEUTICAL

First quarter : Okura Industrial+HISAMITSU PHARMACEUTICAL

Second quarter : Okura Industrial+HISAMITSU PHARMACEUTICAL

Third quarter : Okura Industrial+HISAMITSU PHARMACEUTICAL

Analysis Menu

Outline : Okura Industrial+HISAMITSU PHARMACEUTICAL

Statement : Okura Industrial+HISAMITSU PHARMACEUTICAL

Rating : Okura Industrial+HISAMITSU PHARMACEUTICAL

Indicator : Okura Industrial+HISAMITSU PHARMACEUTICAL

Download : Okura Industrial+HISAMITSU PHARMACEUTICAL

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Kagawa - EDIUNET Prefectures

Kagawa丸亀市 - EDIUNET Prefectures

Saga - EDIUNET Prefectures

Saga鳥栖市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
Okura Industrial	4221	TSE 1st	Chemicals	12	Annual	AA
HISAMITSU PHARMACEUTICAL	4530	TSE 1st	Chemicals	2	Annual	A

Related Company

TSUMURA & CO. (Sales ¥ 105 B)

塩野義製薬 (Sales ¥ 282 B)

Kuraray (Sales ¥ 369 B)

HISAMITSU PHARMACEUTICAL (Sales ¥ 142 B)

Nihon Parkrizing (Sales ¥ 89 B)

Kao (Sales ¥ 1.2 T)

NIHON NOHYAKU (Sales ¥ 47 B)

持田製薬 (Sales ¥ 89 B)

ダイセル (Sales ¥ 358 B)

Otsuka Holdings (Sales ¥ 1.2 T)

関西ペイント (Sales ¥ 294 B)

Mitsubishi Tanabe Pharma (Sales ¥ 419 B)

The Nippon Synthetic Chemical Industry (Sales ¥ 91 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .